Heights Capital Management, Inc Humacyte, Inc. Transaction History
Heights Capital Management, Inc
- $213 Billion
- Q1 2025
A detailed history of Heights Capital Management, Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Heights Capital Management, Inc holds 4,025,000 shares of HUMA stock, worth $9.38 Million. This represents 3.22% of its overall portfolio holdings.
Number of Shares
4,025,000Holding current value
$9.38 Million% of portfolio
3.22%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
181Shares Held
59.9MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$16.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$15.4 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$9.94 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$9.2 Million0.05% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.31MShares$7.72 Million0.12% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $240M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...